GastroAGI Logo
OverviewBlogsAbout
Trending TopicsDaily BriefConference

116 calculators match

Most used

21
MELD-NaAssesses the severity of chronic liver diseaseChild-Pugh ScoreAssesses the prognosis of chronic liver disease, mainly cirrhosisFIB-4 IndexLiver fibrosis scoring indexAPRIAST to platelet ratio — liver fibrosisMaddrey's DFAlcoholic hepatitis severityGlasgow-BlatchfordUpper GI bleed risk stratificationGAHSGlasgow alcoholic hepatitis scoreMontreal IBDIBD classification — CD & UCMayo ScoreUlcerative colitis activityBISAP ScoreBedside index for severity of pancreatitisCLIF-SOFAOrgan failure scoring in cirrhosisAlcohol ContentStandard drinks & alcohol grams calculatorAARC-ACLFAcute-on-chronic liver failure gradePELD / CR ScorePediatric end-stage liver diseaseHarvey-BradshawCrohn's disease activity indexCTSICT severity index — pancreatitisRockall ScoreGI bleed rebleeding & mortality riskCAGEAlcohol use disorder screening (4 questions)MELD 3.0Updated MELD — sex-inclusive formulaAUDIT ScoreAlcohol use disorders identification testVOCAL-Penn ScorePost-operative mortality risk in cirrhosis surgery

Liver & Cirrhosis

17
ALBI GradeAlbumin-bilirubin liver function grade in HCCUKELD ScoreUK model for end-stage liver diseaseMELD-XIMELD excluding INR — for anticoagulated patientsWest Haven CriteriaHepatic encephalopathy gradingMilan CriteriaLiver transplant eligibility in hepatocellular carcinomaLI-RADS v2018 (CT/MRI)Liver observation category from size, APHE and major featuresBCLC StagingHepatocellular carcinoma stage and treatment allocationSimplified AIH CriteriaSimplified criteria for autoimmune hepatitisRevised Original AIH ScoreIAIHG 1999 comprehensive autoimmune hepatitis scoreSAAGSerum-ascites albumin gradient — cause of ascitesR FactorHepatocellular vs cholestatic pattern in liver injuryCLIF-C ACLFMortality prediction in acute-on-chronic liver failureKing's College CriteriaTransplant criteria in acute liver failureGALAD ScoreHCC detection from gender, age, AFP-L3, AFP and DCPMetroticket 2.0AFP-adjusted up-to-seven for HCC transplant eligibilityRUCAMCausality in drug- and herb-induced liver injuryBaveno VII CriteriacACLD, CSPH and sparing screening endoscopy

Fibrosis & MASLD

8
NAFLD Fibrosis ScoreAdvanced fibrosis probability in MASLD/NAFLDBARD ScoreBMI, AST/ALT ratio, diabetes — MASLD fibrosisFatty Liver IndexPredicts hepatic steatosis from routine labsFibrotic NASH Index (FNI)At-risk NASH probability from AST, HbA1c and HDLNAFLD Activity Score (NAS)Histologic activity grade — steatosis, inflammation, ballooningMEFIB IndexMRE + FIB-4 rule for significant fibrosis (≥F2) in MASLDFAST ScoreFibroScan-AST — at-risk NASH from LSM, CAP and ASTSAFE ScoreSteatosis-Associated Fibrosis Estimator for MASLD in primary care

Pancreas & Biliary

8
Ranson's CriteriaAcute pancreatitis severity at 48 hoursGlasgow-Imrie CriteriaAcute pancreatitis severity — the PANCREAS criteriaHAPSHarmless acute pancreatitis scoreTokyo Guidelines — CholangitisTG18 diagnosis and severity grade for acute cholangitisTokyo Guidelines — CholecystitisTG18 diagnosis and severity grade for acute cholecystitisBiliary Pain (Rome IV)Rome IV — defining biliary-type pain before interventionFunctional Pancreatic SODRome IV — pancreatic sphincter of Oddi disorderRevised Atlanta ClassificationAcute pancreatitis severity — mild, moderately severe, severe

IBD

9
Truelove & Witts CriteriaAcute severe ulcerative colitis — admission decisionUCEISUlcerative colitis endoscopic index of severitySCCAISimple clinical colitis activity index — symptoms onlyCDAICrohn's disease activity index — the trial standardSES-CDEndoscopic severity in Crohn's diseasePUCAIPaediatric ulcerative colitis activity indexTravis (Oxford) CriteriaDay 3 colectomy risk in acute severe ulcerative colitisHo IndexDay 3 steroid failure risk in acute severe ulcerative colitisRutgeerts ScorePostoperative Crohn's recurrence at ileocolonoscopy

GI Bleeding

7
EVendo ScorePredicts oesophageal varices needing treatmentForrest ClassificationPeptic ulcer bleeding — rebleeding risk at endoscopyAIMS65 ScoreUpper GI bleed mortality — five bedside criteriaOakland ScoreSafe-discharge risk for acute lower GI bleedingABC ScoreAge, blood tests, comorbidities — GI bleed mortalitySarin ClassificationEndoscopic classification of gastric varicesEGUS (Gastric Ulcer)Malignancy risk in a gastric ulcer, and who needs repeat endoscopy

Alcohol

2
ABIC ScoreAge, bilirubin, INR, creatinine — alcoholic hepatitisLille ModelSteroid response at day 7 in alcoholic hepatitis

Upper GI

4
Chicago Classification v4.0Oesophageal motility pattern from high-resolution manometryLA Classification (Oesophagitis)Los Angeles grade A–D for erosive oesophagitisPrague C & M CriteriaCircumferential and maximal extent of Barrett's oesophagusEREFS (Eosinophilic Oesophagitis)Endoscopic reference score — oedema, rings, exudates, furrows, stricture

Colorectal

3
Boston Bowel Prep ScaleColonoscopy preparation adequacy by segmentStool Osmotic GapOsmotic vs secretory diarrhoea from stool electrolytesATLAS Score (C. difficile)Predicted response to therapy in Clostridioides difficile infection

Functional GI

37
Bristol Stool ScaleStool form types 1–7 and colonic transitRome IV Criteria for IBSIrritable bowel syndrome diagnosis and subtypeFunctional ConstipationRome IV — two of six items, IBS excludedOpioid-Induced ConstipationRome IV — constipation tied to opioid therapyFunctional DiarrhoeaRome IV — loose stools without predominant painFunctional Bloating / DistensionRome IV — bloating without other bowel disorder criteriaUnspecified Functional Bowel DisorderRome IV — bowel symptoms fitting no other categoryCentrally Mediated Abdominal Pain (CAPS)Rome IV — continuous pain unrelated to gut eventsNarcotic Bowel SyndromeRome IV — opioid-induced hyperalgesia of the gutFaecal Incontinence (Rome IV)Rome IV — the criteria, and why nobody is askedFunctional Anorectal PainLevator ani, unspecified pain and proctalgia fugaxFunctional Defecation DisordersRome IV — dyssynergia and inadequate propulsionInfant RegurgitationRome IV — the happy spitter, and the alarm features that rule it outInfant ColicRome IV — recurrent unexplained crying in a well infant under 5 monthsInfant DyscheziaRome IV — straining before a soft stool, and why not to intervenePaediatric Functional ConstipationRome IV — two of six over one month, with overflow soiling as a criterionToddler's DiarrhoeaRome IV functional diarrhoea of childhood — painless, thriving childPaediatric Cyclic Vomiting SyndromeRome IV — both age bands, with different criteria for eachPaediatric Rumination SyndromeRome IV — infant and child/adolescent criteriaFunctional Nausea & Vomiting (Children)Rome IV — two separate disorders that can be met togetherAerophagiaRome IV — distension that increases through the dayPaediatric Functional DyspepsiaRome IV — four times a month, with PDS and EPS subtypingPaediatric Irritable Bowel SyndromeRome IV — plus the constipation clause clinicians missAbdominal MigraineRome IV — stereotypical incapacitating episodes weeks apartFunctional Abdominal Pain — NOSRome IV — the residual category, reached after the other threeNonretentive Faecal IncontinenceRome IV — soiling without retention, where laxatives make it worseFunctional DyspepsiaRome IV — with PDS and EPS subtypingRumination SyndromeRome IV — effortless regurgitation without retchingCyclic Vomiting SyndromeRome IV — stereotypical episodic vomitingCannabinoid HyperemesisRome IV — CVS pattern relieved by cannabis cessationChronic Nausea & VomitingRome IV — chronic nausea and vomiting syndromeBelching DisordersRome IV — supragastric vs gastric belchingFunctional HeartburnRome IV — heartburn with normal acid exposureReflux HypersensitivityRome IV — normal acid exposure, positive symptom associationFunctional Chest PainRome IV — non-cardiac, non-reflux chest painGlobusRome IV — painless lump-in-throat sensationFunctional DysphagiaRome IV — dysphagia with normal endoscopy and manometry
  1. Calculators
  2. /
  3. Travis (Oxford) Criteria
IBD

Travis (Oxford) Criteria

Day 3 colectomy risk in acute severe ulcerative colitis

The count on day 3 of intravenous steroids, not the admission figure.

The threshold is 45 mg/L, which is 4.5 mg/dL.

Applied on day 3 of intravenous corticosteroids in a patient admitted with acute severe ulcerative colitis. It is a trigger to have the rescue-therapy and surgical conversation on day 3 rather than day 7 — not a decision to operate.

When to use
Use it on day 3 of intravenous steroids in a patient admitted with acute severe ulcerative colitis by Truelove and Witts criteria. Day 3 is the point of the whole exercise: the criteria exist to move the rescue-therapy and surgical conversation forward from day 7, when it used to happen, to a point where there is still time to act on it.
Why use it
Because the alternative is waiting to see, and waiting has a cost that falls entirely on the patient. Before these criteria, failure of intravenous steroids tended to declare itself around day 7, by which time the patient had been sick for a week, was more malnourished, more deconditioned and more thrombotic, and any subsequent colectomy was being performed under worse conditions. Travis showed that the information needed to identify most of those patients is already present on day 3 in two variables anyone can obtain at no cost. What the criteria buy is not a decision but time — time to involve the surgeons, plan rescue therapy properly, and have an unhurried conversation with a patient who is still well enough to participate in it.
Formula, evidence and interpretation

About the Travis (Oxford) Criteria for Acute Severe Ulcerative Colitis

Applied on day 3 of intravenous corticosteroids: more than eight stools that day, or a stool frequency between three and eight together with a CRP above 45 mg/L. Either arm predicts roughly an 85% chance of colectomy during the same admission. Note the structure, because it is widely misquoted — the CRP threshold applies only within the three-to-eight stool window. The paper's own Conclusions paraphrase it loosely as 'more than 8 stools or CRP above 45', dropping that condition, and most secondary sources reproduce the loose version. The two disagree for a patient who is responding, with fewer than three stools but a CRP that has not yet fallen.

On this page

  • Formula
  • Interpreting the result
  • Inputs
  • What it returns
  • How it is calculated
  • Facts & figures
  • Evidence
  • How it compares
  • Pearls & pitfalls
  • Critical actions
  • Why it exists
  • About the creator
  • Limitations
  • If you are the patient
  • FAQ
  • Related calculators
  • References

Formula

On day 3 of intravenous corticosteroids: stool frequency > 8 per day OR stool frequency 3-8 per day AND CRP > 45 mg/L -> approximately 85% required colectomy on that admission WIDELY REPRODUCED LOOSER FORM (from the paper's Conclusions): stool frequency > 8 per day OR CRP > 45 mg/L The two diverge when stool frequency is under 3 with a CRP above 45.
More than 8 stools
Sufficient on its own, whatever the CRP. A patient still passing nine or more stools on day 3 of intravenous steroids has not responded.
3 to 8 stools with CRP above 45 mg/L
The combined arm. Both conditions are required — the CRP threshold is not a free-standing criterion, though it is very commonly quoted as one.
Day 3
Not day 2 and not day 5. The criteria were derived at this specific point, and applying them earlier or later is extrapolation.
  • Derived in 51 episodes of severe colitis defined by Truelove and Witts criteria, all treated with intravenous and rectal hydrocortisone.
  • The paper also defines a day 7 checkpoint: more than 3 stools daily with visible blood carries a 60% chance of continuing symptoms and a 40% chance of colectomy over the following months.
  • Ciclosporin was used in 14 of the 51 episodes, and the modern rescue-therapy landscape differs substantially from 1996.
  • The criteria predict colectomy on that admission — they do not indicate it.

Interpreting the result

A positive result should change what happens that day, not that week. Involve the colorectal surgical team while the patient is still relatively well, rather than as a rescue when medical therapy has visibly failed — the outcome of colectomy in acute severe colitis depends heavily on how deconditioned the patient has become by the time it happens. Make an active decision about rescue therapy with infliximab or ciclosporin rather than deferring it. Before attributing failure to refractory colitis, exclude Clostridioides difficile and cytomegalovirus superinfection, both of which reproduce steroid non-response and are treated differently. Check that thromboprophylaxis is prescribed: acute severe colitis is strongly prothrombotic, and bloody diarrhoea is not a contraindication — this is among the most common omissions on these admissions. A negative result is not a discharge decision and does not mean the admission is going well; continue daily review and reassess formally at day 7, where the paper's second finding applies. Finally, be deliberate about which version of the rule is being applied, since the looser paraphrase in wide circulation will flag some responding patients that the operational rule does not.

ScoreBandWhat it meansAction
More than 8 stools on day 3High risk of colectomyApproximately 85% required colectomy on that admissionInvolve the surgical team today; decide on rescue therapy; exclude C. difficile and CMV
3–8 stools with CRP above 45 mg/LHigh risk of colectomyThe combined arm — same prediction, arising in a more ambiguous clinical pictureSame actions; the intermediate stool count makes early surgical involvement more valuable, not less
Criteria not metNot high riskDoes not predict a favourable admissionContinue intravenous steroids with daily review; reassess formally at day 7

What the Travis (Oxford) Criteria needs (2 inputs)

Stool frequency on day 3
The count on day 3 of intravenous steroids, not the admission figure. More than eight satisfies the criteria on its own; three to eight opens the CRP arm.
CRP on day 3
The threshold is 45 mg/L, equivalently 4.5 mg/dL. It applies only when the stool frequency is between three and eight — a detail lost in most reproductions of the rule.

What it returns

High risk or not high risk
Binary. The criteria were designed as a trigger rather than a graded score, which is both their strength and their main limitation.
Which arm was met
Reported explicitly, since the stool-only arm and the combined arm carry the same prediction but arise in different clinical pictures.

How it is calculated

The two variables are not arbitrary. Stool frequency is the most direct available measure of how much colon is still inflamed and failing to absorb, and it responds quickly when steroids are working — so a patient still passing nine stools on day 3 is giving a fairly unambiguous signal. CRP measures the acute-phase response driving that inflammation and, importantly, falls with a different time course, which is why it adds information rather than duplicating the stool count. The structure of the rule follows from that difference. A very high stool frequency is severe enough to stand alone. An intermediate stool frequency is genuinely ambiguous — it might represent a partial response or a plateau — and it is precisely there that a persistently raised CRP resolves the ambiguity by showing the inflammatory drive has not been switched off. That is why the CRP condition is nested inside the three-to-eight window rather than free-standing: below three stools the patient is responding and a lagging CRP means little, and above eight the stool count has already answered the question.

Facts & figures

The two statements of the rule, and where they disagree
SourceWordingEffect
Paper's ResultsMore than 8 stools, or 3–8 stools together with CRP above 45 mg/LThe operational rule — CRP applies only in the 3–8 window
Paper's ConclusionsFrequent stools (over 8/day), or raised CRP (over 45 mg/L)Drops the stool condition on the CRP arm
Where they divergeFewer than 3 stools with CRP above 45Loose form flags a responding patient; the operational rule does not

Both forms come from the same paper, which is why the looser one is so widely reproduced. This calculator implements the Results wording.

The day 3 and day 7 checkpoints from the same study
TimepointCriterionPredicted outcome
Day 3More than 8 stools, or 3–8 with CRP above 45Approximately 85% colectomy on that admission
Day 7More than 3 stools daily with visible blood60% chance of continuing symptoms; 40% chance of colectomy over following months

The day 7 finding is often forgotten. A patient who passes the day 3 checkpoint still needs the day 7 assessment.

Evidence

Derivation — Oxford, Travis and colleagues, 1996

1996

A prospective study of 51 consecutive episodes of severe ulcerative colitis defined by Truelove and Witts criteria, affecting 49 patients admitted to the John Radcliffe Hospital, monitoring 36 clinical, laboratory and radiographic variables. All episodes were treated with intravenous and rectal hydrocortisone; 14 also received ciclosporin.

Stool frequency and CRP distinguished outcomes during the first five days. On day 3, more than eight stools, or a frequency of three to eight with CRP above 45 mg/L, predicted colectomy on that admission in approximately 85%.

The population it is applied to — Truelove and Witts

1955

The 1955 criteria defining acute severe ulcerative colitis, which determine who is eligible for the Travis assessment in the first place.

Remain the entry criteria for the admission; the Travis rule is a day 3 checkpoint within it rather than a diagnostic tool.

Contemporary comparator — the Ho index

2004

A 2004 Edinburgh cohort of 167 consecutive patients with severe ulcerative colitis, producing a graded score from stool frequency, colonic dilatation and albumin.

Reported roughly 85% sensitivity and 75% specificity for corticosteroid failure at a threshold of 4, and adds colonic dilatation, which Travis does not consider at all.

How it compares

Travis (Oxford) Criteria vs Ho index

Same question, same day, different shape — binary versus graded, and only Ho sees colonic dilatation.

Both are day 3 predictors of steroid failure in acute severe colitis, and they use overlapping inputs. Travis is binary and uses stool frequency and CRP; Ho is a 0–9 score using stool frequency, colonic dilatation and albumin. The practical differences are that Ho gives an intermediate band where Travis forces a yes or no, and that Ho counts colonic dilatation as four points — enough to reach high risk on its own — while Travis does not consider it at all. Running both is reasonable, and where they disagree the disagreement usually locates the clinical question rather than obscuring it.

Open the Ho index calculator →

Travis (Oxford) Criteria vs Truelove and Witts criteria

Truelove and Witts gets the patient admitted; Travis decides what happens on day 3.

The two sit in sequence and are frequently confused. Truelove and Witts defines acute severe ulcerative colitis at presentation — six or more bloody stools daily plus a systemic feature — and is what triggers admission and intravenous steroids. The Travis criteria are applied three days into that treatment and ask a different question: is this working. Travis was derived specifically in patients defined by Truelove and Witts, so applying it to a less sick population is outside what it was built for.

Open the Truelove and Witts criteria calculator →

Travis (Oxford) Criteria vs UCEIS

Endoscopic severity at one moment against clinical trajectory over three days — related but not interchangeable.

UCEIS grades what the mucosa looks like, scoring vascular pattern, bleeding and erosions, and a high score at admission does carry prognostic weight in acute severe colitis. Travis measures how the patient is behaving over the first three days of treatment. The distinction matters because endoscopic severity is fixed at the time of the procedure while the Travis inputs are dynamic, and it is the trajectory that determines whether steroids are working. In practice a severe UCEIS at admission raises the prior, and the day 3 assessment tests it.

Open the UCEIS calculator →Travis SP, Farrant JM, Ricketts C, et al. Predicting outcome in severe ulcerative colitis. Gut. 1996;38(6):905-910.

Pearls & pitfalls

  • The CRP threshold applies only when stool frequency is between three and eight. The free-standing 'CRP above 45' version is a paraphrase from the paper's Conclusions, not its analysis.
  • Apply on day 3 specifically — the criteria were derived at that timepoint and using them on day 2 or day 5 is extrapolation.
  • Use the day 3 stool count, not the admission figure.
  • The criteria predict colectomy; they do not indicate it. The decision remains clinical and multidisciplinary.
  • A negative result is not reassurance — it predicts nothing about the day 7 checkpoint, which still applies.
  • Exclude C. difficile and CMV before attributing steroid failure to refractory colitis.
  • Prescribe thromboprophylaxis. Acute severe colitis is strongly prothrombotic and bloody stool is not a contraindication — one of the commonest omissions on these admissions.
  • Involve the colorectal team on the day the criteria are met, while the patient is still well enough for an elective-quality operation.
  • CRP can be falsely low in patients already on immunosuppression, weakening the combined arm.
  • The criteria say nothing about colonic dilatation; the Ho index does, and toxic megacolon needs recognising independently.

Critical actions

  • Confirm the patient meets Truelove and Witts criteria for acute severe colitis before applying this rule.
  • Record the stool count on day 3 of intravenous steroids specifically.
  • Send stool for C. difficile toxin and consider CMV assessment if the trajectory stalls.
  • Check that thromboprophylaxis is prescribed and being given.
  • Involve the colorectal surgical team the day the criteria are met.
  • Make an explicit decision on rescue therapy rather than deferring it to the next ward round.
  • Obtain a plain abdominal radiograph to exclude colonic dilatation, which these criteria do not assess.
  • Reassess at day 7 regardless of the day 3 result.

Why this score exists

It is unusual for a paper to state its own finding two different ways, and this one does. The Results section gives the operational rule — more than eight stools, or three to eight together with a CRP above 45 — while the Conclusions compress it to 'frequent stools, or raised CRP', dropping the condition that ties the two together. Both are in the same abstract. The compressed version is easier to remember and it is the one that propagated, which is why most secondary sources, and a good many calculators, implement a rule the paper's own analysis does not support. The difference is small in the population the criteria were built for, since a patient meeting Truelove and Witts is unlikely to be passing fewer than three stools on day 3 — but it is not nothing, and it points the wrong way: the looser rule flags a patient whose stool frequency has fallen below three, which is to say someone who is getting better. Encoding the Results wording costs nothing and is what the data actually showed.

About the creator

  • Simon P. L. Travis

    First author; inflammatory bowel disease, Oxford

    Led the study that moved the acute severe colitis decision point from day 7 to day 3.

  • Derek P. Jewell

    Senior author; Oxford inflammatory bowel disease unit

    Supervised the prospective series from which the criteria were derived.

  • Neil J. Mortensen

    Co-author; colorectal surgery

    Contributed the surgical perspective that gives the criteria their purpose — earlier involvement rather than later rescue.

Limitations

  • Derived in 51 episodes at a single centre in 1996, a small sample by modern standards.
  • The therapeutic landscape has changed completely — infliximab was not available, and ciclosporin was used in only 14 episodes.
  • Binary output, so a patient just short of the threshold and one far below it are reported identically.
  • Colonic dilatation is not considered at all, despite being an independent indication for surgery.
  • CRP may be falsely low in patients already on immunosuppression or biologics, weakening the combined arm.
  • The rule is stated two ways in the source paper, and the looser version is more widely implemented than the operational one.
  • It predicts colectomy on that admission only, and says nothing about the medium-term course of patients who avoid surgery.
  • Stool frequency is self-reported or nursing-recorded and is not always accurately counted.

If you are the patient

If you have been admitted with a severe flare of ulcerative colitis, you will usually be started on steroids given through a drip. On the third day, the team will look at two simple things: how many times you are opening your bowels, and a blood test called CRP that measures inflammation. This is not an extra test — it is a planned checkpoint. The reason for checking on day three rather than waiting longer is that if the steroids are not working, it is much better to know early. It gives time to try a second medicine, such as infliximab or ciclosporin, and time to involve the surgical team for a proper discussion while you are still feeling relatively strong. In the past this conversation often happened around day seven, by which point people were weaker and any operation was harder to recover from. If the checkpoint suggests the steroids are not working, it does not mean you will definitely need surgery, and it certainly does not mean surgery is happening that day. It means the team will act now rather than wait — starting a second medicine, and making sure a surgeon has met you in case one is needed. If you pass the checkpoint, that is encouraging, but you will still be reviewed every day and assessed again around day seven. Two things are worth asking about: whether you are on a blood-thinning injection, which is important in a colitis flare even though you are passing blood, and whether infections such as C. difficile have been tested for, since they can look exactly like a flare that is not responding.

Frequently asked questions

What are the Travis (Oxford) criteria?#

Applied on day 3 of intravenous corticosteroids in acute severe ulcerative colitis: more than eight stools that day, or a stool frequency between three and eight together with a CRP above 45 mg/L. Either predicts roughly an 85% chance of colectomy during the same admission.

Is it 'more than 8 stools OR CRP above 45'?#

Not in the paper's analysis. The Results state the rule as more than eight stools, or three to eight stools together with a CRP above 45 — the CRP threshold is conditional on the stool frequency. The paper's Conclusions paraphrase it without that condition, and that looser form is what most secondary sources reproduce. This calculator implements the Results wording.

Where do the two versions disagree?#

For a patient with fewer than three stools on day 3 and a CRP still above 45. The operational rule does not flag them, because a stool frequency that low means they are responding and a lagging CRP adds little. The loose form does flag them. The divergence is uncommon in a Truelove and Witts population but points the wrong way, since it identifies patients who are getting better.

Why day 3 specifically?#

Because that is where the criteria were derived, and because it is early enough to act on. Before this work, steroid failure typically declared itself around day 7, by which time the patient was more malnourished, more deconditioned and more thrombotic, and any colectomy was performed under worse conditions. Applying the rule on day 2 or day 5 is extrapolation.

Does meeting the criteria mean the patient needs surgery?#

No. The criteria predict colectomy; they do not indicate it. What they should trigger is earlier action — involving the colorectal team while the patient is still well, making an active decision about rescue therapy with infliximab or ciclosporin, and excluding C. difficile and CMV superinfection before concluding the colitis itself is refractory.

What if the criteria are not met?#

Continue intravenous steroids with daily review. A negative day 3 result is not reassurance about the admission and is not a discharge decision. The same study defines a day 7 checkpoint that still applies: more than three stools daily with visible blood carries a 60% chance of continuing symptoms and a 40% chance of colectomy over the following months.

How do the Travis criteria compare with the Ho index?#

They answer the same question on the same day with different structure. Travis is binary and uses stool frequency and CRP. Ho is a graded 0–9 score using stool frequency, colonic dilatation and albumin, so it offers an intermediate band and — importantly — counts colonic dilatation, which Travis ignores entirely. Running both is reasonable, since dilatation alone reaches high risk on the Ho index.

What is most often missed on these admissions?#

Thromboprophylaxis. Acute severe colitis is a strongly prothrombotic state and bloody diarrhoea is not a contraindication to prophylactic anticoagulation, yet it is frequently withheld for exactly that reason. After that, failure to exclude C. difficile and cytomegalovirus, both of which mimic steroid-refractory colitis and are managed differently.

Related calculators

  • Ho Index — Day 3 steroid failure risk in acute severe ulcerative colitis
  • Truelove & Witts Criteria — Acute severe ulcerative colitis — admission decision
  • UCEIS — Ulcerative colitis endoscopic index of severity
  • Mayo Score — Ulcerative colitis activity
  • SCCAI — Simple clinical colitis activity index — symptoms only

References

Original / primary reference

  1. Travis SP, Farrant JM, Ricketts C, Nolan DJ, Mortensen NM, Kettlewell MG, Jewell DP. Predicting outcome in severe ulcerative colitis. Gut. 1996;38(6):905-910.

Comparator score

  1. Ho GT, Mowat C, Goddard CJ, Fennell JM, Shah NB, Prescott RJ, Satsangi J. Predicting the outcome of severe ulcerative colitis: development of a novel risk score to aid early selection of patients for second-line medical therapy or surgery. Aliment Pharmacol Ther. 2004;19(10):1079-1087.

Clinical practice guidelines

  1. Rubin DT, Ananthakrishnan AN, Siegel CA, Sauer BG, Long MD. ACG Clinical Guideline: Ulcerative Colitis in Adults. Am J Gastroenterol. 2019;114(3):384-413.
  2. Lamb CA, Kennedy NA, Raine T, Hendy PA, Smith PJ, Limdi JK, et al. British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults. Gut. 2019;68(Suppl 3):s1-s106.

Last updated August 1, 2026. Clinical knowledge base written and curated by GastroAGI Team from primary medical literature.

Written from primary literature and not yet independently clinically reviewed.

For use by qualified healthcare professionals. This calculator supports clinical judgement and does not replace it.